Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Shares Outstanding (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Shares Outstanding for 3 consecutive years, with $24.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 1.25% to $24.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.6 million, a 1.25% increase, with the full-year FY2025 number at $24.6 million, up 1.25% from a year prior.
  • Shares Outstanding was $24.6 million for Q4 2025 at Artiva Biotherapeutics, roughly flat from $24.5 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $24.6 million in Q4 2025 to a low of $805199.0 in Q2 2023.
  • A 3-year average of $13.8 million and a median of $24.3 million in 2024 define the central range for Shares Outstanding.
  • Biggest YoY gain for Shares Outstanding was 2908.69% in 2025; the steepest drop was 1.06% in 2025.
  • Artiva Biotherapeutics' Shares Outstanding stood at $809758.0 in 2023, then soared by 2899.86% to $24.3 million in 2024, then rose by 1.25% to $24.6 million in 2025.
  • Per Business Quant, the three most recent readings for ARTV's Shares Outstanding are $24.6 million (Q4 2025), $24.5 million (Q3 2025), and $24.4 million (Q2 2025).